Botanical species · safety record

Ophiopogon japonicus

The EFSA Compendium of Botanicals holds 5 constituent measurements for Ophiopogon japonicus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ophiopogon japonicus (Thunb.) Ker Gawl.

5Constituent measurements

0Safety records

3Cited sources

784Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 784 licensed products naming Ophiopogon japonicus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
decoction
solid

Source material stated

Dried root tuber
Dried tuber
Radix
Root
Root extract
Root tuber(s)
Tuber
Tuber (centre-removed)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Steroidal saponins	Roots and other underground parts used as staple food	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Anthraquinones	Roots and other underground parts	—	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Coumarins	Roots and other underground parts	—	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Isoflavones	Roots and other underground parts	—	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Steroidal glycosides	Roots and other underground parts used as staple food	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Cheng, Z.-H., Wu, T., Li, L.-Z., Liu, N., Yu, B.-Y., Xu, L.-S. Studies on the liposoluble components from tuber of Ophiopogon japonicus. Chinese pharmaceutical journal, 2005, vol. 40, no. 5, p. 337-341.
Watanabe, Yoshiaki., Sanada, Shuichi., Tada, Akihiro., Shoji, Junzo. Studies on the constituents of Ophiopogonis tuber. IV. On the structures of ophiopogonin A, B', C, C', and D'. Chemical Pharmaceutical Bulletin, 1977, p. 3049-3055.
Li, Ning., Zhang, Liang., Zeng, Ke-Wu., Zhou, Yuan., Zhang, Jia-Yu., Che, Yan-Yun., Tu, Peng-Fei. Cytotoxic steroidal saponins from Ophiopogon japonicus. STEROIDS, 2013, vol. 78, no. 1, p. 1-7. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature